Breve curriculum vitae
EDUCATION
05/2019 – current: Postdoctoral fellow, University of Pisa, Pisa (Italy)
11/2015 – 10/2019: PhD student in Molecular Medicine, University of Siena, Siena (Italy); “Malignant Pleural Mesothelioma: an investigation on relevant cancer genes and potentially repositionable drugs”.
09/2009 – 05/2015: Master Degree in Drug Chemistry and Technology, University of Perugia, Perugia (Italy); "The fusion of single-chain antibodies and cell-penetrating peptides. Construction, expression and characterization".
RESEARCH EXPERIENCE
11/2018 - 04/2019: Internship at University of Pisa, Pisa (Italy) ;Supervisor: Professor Stefano Landi-Drug screening in Malignant Pleural Mesothelioma cell lines
09/2017 - 03/2018: Internship at Bart Cancer Institute, Queen University of London, London (UK);Supervisor: Professor Sarah-Anne Martin -Drug screening in Malignant Pleural Mesothelioma cell lines
01/2014 - 06/2014: Internship at Karlstad University, Karlstad (Sweden);Supervisor: Professor Patrik Holm-Study of cell-penetrating peptides
08/2013 - 11/2013: Internship at Mylan School of Pharmacy, Duquesne University, Pittsburgh (USA);Supervisor: Dr. J. Douglas Bricker-Study of the American pharmaceutical system. Training concerning patient-related activity, student and research laboratories
Pubblicazioni e abstracts
Mesothelin promoter variants are associated with increased Soluble-Mesothelin related Peptide (SMRP) levels in asbestos-exposed individuals. Occupational and Enviromental, June 2017; 74(6):456-463. doi: 10.1136/oemed-2016-104024
Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018). Lung Cancer, January 2019; 127:138-145. doi: 10.1016/j.lungcan.2018.11.034
